Scholarly Index
Min Wang
Central South University; 29,986 total citations; 548 total publications; best world rank #109
Central South University
29,986Total citations
548Total publications
80H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| RNA modifications and cancer | Lifetime | 697 | CN 84 | 98.66 |
| Ubiquitin and proteasome pathways | Lifetime | 405 | CN 31 | 98.17 |
| Angiogenesis and VEGF in Cancer | Lifetime | 351 | CN 14 | 97.80 |
| interferon and immune responses | Lifetime | 925 | CN 110 | 95.19 |
| Lymphatic System and Diseases | Lifetime | 359 | CN 11 | 93.19 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 866 | CN 31 | 95.02 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 995 | CN 101 | 93.40 |
| RNA modifications and cancer | 2021-2025 | 109 | CN 71 | 98.81 |
| Epigenetics and DNA Methylation | 2021-2025 | 234 | CN 89 | 95.77 |
| Cancer-related molecular mechanisms research | 2021-2025 | 799 | CN 615 | 94.23 |
| Ubiquitin and proteasome pathways | 2021-2025 | 396 | CN 171 | 88.79 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 793 | CN 253 | 81.99 |
| Cancer-related gene regulation | 2021-2025 | 951 | CN 647 | 76.63 |
| Vascular Malformations Diagnosis and Treatment | 2021-2025 | 899 | CN 125 | 78.22 |
| Signaling Pathways in Disease | 2021-2025 | 297 | CN 118 | 68.00 |